360 related articles for article (PubMed ID: 18027980)
1. Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide.
Smith BC; Denu JM
Biochemistry; 2007 Dec; 46(50):14478-86. PubMed ID: 18027980
[TBL] [Abstract][Full Text] [Related]
2. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
Borra MT; Langer MR; Slama JT; Denu JM
Biochemistry; 2004 Aug; 43(30):9877-87. PubMed ID: 15274642
[TBL] [Abstract][Full Text] [Related]
3. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry.
Sauve AA; Schramm VL
Biochemistry; 2003 Aug; 42(31):9249-56. PubMed ID: 12899610
[TBL] [Abstract][Full Text] [Related]
4. Nepsilon-thioacetyl-lysine: a multi-facet functional probe for enzymatic protein lysine Nepsilon-deacetylation.
Fatkins DG; Monnot AD; Zheng W
Bioorg Med Chem Lett; 2006 Jul; 16(14):3651-6. PubMed ID: 16697640
[TBL] [Abstract][Full Text] [Related]
5. Sirtuin mechanism and inhibition: explored with N(ε)-acetyl-lysine analogs.
Hirsch BM; Zheng W
Mol Biosyst; 2011 Jan; 7(1):16-28. PubMed ID: 20842312
[TBL] [Abstract][Full Text] [Related]
6. N(epsilon)-Modified lysine containing inhibitors for SIRT1 and SIRT2.
Huhtiniemi T; Suuronen T; Lahtela-Kakkonen M; Bruijn T; Jääskeläinen S; Poso A; Salminen A; Leppänen J; Jarho E
Bioorg Med Chem; 2010 Aug; 18(15):5616-25. PubMed ID: 20630764
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human sirtuins by in situ generation of an acetylated lysine-ADP-ribose conjugate.
Asaba T; Suzuki T; Ueda R; Tsumoto H; Nakagawa H; Miyata N
J Am Chem Soc; 2009 May; 131(20):6989-96. PubMed ID: 19413317
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases.
Smith BC; Denu JM
J Biol Chem; 2007 Dec; 282(51):37256-65. PubMed ID: 17951578
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence assay of SIRT protein deacetylases using an acetylated peptide substrate and a secondary trypsin reaction.
Marcotte PA; Richardson PL; Guo J; Barrett LW; Xu N; Gunasekera A; Glaser KB
Anal Biochem; 2004 Sep; 332(1):90-9. PubMed ID: 15301953
[TBL] [Abstract][Full Text] [Related]
10. Role of NAD(+) in the deacetylase activity of the SIR2-like proteins.
Landry J; Slama JT; Sternglanz R
Biochem Biophys Res Commun; 2000 Nov; 278(3):685-90. PubMed ID: 11095969
[TBL] [Abstract][Full Text] [Related]
11. Insights into the sirtuin mechanism from ternary complexes containing NAD+ and acetylated peptide.
Hoff KG; Avalos JL; Sens K; Wolberger C
Structure; 2006 Aug; 14(8):1231-40. PubMed ID: 16905097
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases.
Zhao K; Harshaw R; Chai X; Marmorstein R
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8563-8. PubMed ID: 15150415
[TBL] [Abstract][Full Text] [Related]
13. Identification of a cell-active non-peptide sirtuin inhibitor containing N-thioacetyl lysine.
Suzuki T; Asaba T; Imai E; Tsumoto H; Nakagawa H; Miyata N
Bioorg Med Chem Lett; 2009 Oct; 19(19):5670-2. PubMed ID: 19700324
[TBL] [Abstract][Full Text] [Related]
14. The Sir 2 family of protein deacetylases.
Denu JM
Curr Opin Chem Biol; 2005 Oct; 9(5):431-40. PubMed ID: 16122969
[TBL] [Abstract][Full Text] [Related]
15. Sir2 protein deacetylases: evidence for chemical intermediates and functions of a conserved histidine.
Smith BC; Denu JM
Biochemistry; 2006 Jan; 45(1):272-82. PubMed ID: 16388603
[TBL] [Abstract][Full Text] [Related]
16. Small molecule regulation of Sir2 protein deacetylases.
Grubisha O; Smith BC; Denu JM
FEBS J; 2005 Sep; 272(18):4607-16. PubMed ID: 16156783
[TBL] [Abstract][Full Text] [Related]
17. N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors.
Kiviranta PH; Suuronen T; Wallén EA; Leppänen J; Tervonen J; Kyrylenko S; Salminen A; Poso A; Jarho EM
J Med Chem; 2009 Apr; 52(7):2153-6. PubMed ID: 19296597
[TBL] [Abstract][Full Text] [Related]
18. Capillary electrophoresis-based sirtuin assay using non-peptide substrates.
Fan Y; Hense M; Ludewig R; Weisgerber C; Scriba GK
J Pharm Biomed Anal; 2011 Mar; 54(4):772-8. PubMed ID: 21074959
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases.
Jackson MD; Schmidt MT; Oppenheimer NJ; Denu JM
J Biol Chem; 2003 Dec; 278(51):50985-98. PubMed ID: 14522996
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.
Avalos JL; Bever KM; Wolberger C
Mol Cell; 2005 Mar; 17(6):855-68. PubMed ID: 15780941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
